Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Sitagliptin / Metformin Hydrochloride vs JANUMET 50 mg / 500 mg under Fed Conditions in Healthy Thai Volunteers
TCTR20220302002Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sitagliptin + metformin, sitagliptin and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by International Bio Service. Primary endpoint: Primary pharmacokinetic bioequivalence endpoints. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
sitagliptin + metforminsitagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20220302002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220302002.